Loading markets…

Moderna, Inc. (MRNA) forecast

Moderna, Inc. (MRNA) forecast: price $184.27, trailing P/E -30.80, forward P/E 374.91. How to read the street's path.

$184.27Price
$73.57BMarket cap
-30.80P/E ?
374.91Forward P/E ?
0.00%Dividend yield ?

The live MRNA price is $184.27. Trailing P/E is -30.80 and forward P/E is 374.91. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the MRNA forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full MRNA quote · Dividends · Price prediction · Academy

Questions

What is MRNA's forward P/E?

The latest forward P/E on Stocklytics is 374.91, against a trailing P/E of -30.80 and a price of $184.27.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.